In vivo and in vitro induction of IL-6 by Quillaja saponaria Molina triterpenoid formulations

被引:27
|
作者
Behboudi, S
Morein, B
VillacresEriksson, M
机构
[1] Swed. Univ. of Agricultural Sciences, Dept. of Veterinary Microbiology, Section of Virology, Uppsala
[2] Swed. Univ. of Agricultural Sciences, Dept. of Veterinary Microbiology, Sectio of Virology
关键词
iscoms; adjuvants; APC; IL-6; vaccines;
D O I
10.1006/cyto.1997.0219
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quillaja saponaria Molina and some of the defined Quillaja components are potent adjuvants, An important function of adjuvants is the activation of antigen-presenting cells (APC), a prerequisite for the development of immune responses, Interleukin 6 (IL-6) has been identified as a key factor in the generation of cytolytic T lymphocytes, which constitute an important effector mechanism elicited by immune-stimulatory complex (iscom)-borne antigens, To identify factors relevant to the unique property of iscoms to mediate CTL responses, we analysed the capacity of different defined Quillaja triterpenoid components in various formulations to stimulate production of IL-6 by APC in vitro and in vivo. The iscom formed with Quillaja adjuvant and incorporated influenza virus envelope proteins elicited the highest secretion of IL-6, The production of IL-6 was also stimulated by the antigen free matrix of the iscom and even by the Quillaja triterpenoids as free components albeit to a significantly lesser extent. Among the various combinations of QH-A and QH-C tested and also the original semipurified spikoside, the QH 7.0.3 matrix was the most efficient formulation for activation of IL-6 production by APC, In general, an increasing proportion of QH-A vs QH-C increases the capacity to activate APC, The results demonstrate that the incorporated antigen and the adjuvant component in the same particle have the synergistic effects on immunogenicity. (C) 1997 Academic Press Limited.
引用
收藏
页码:682 / 687
页数:6
相关论文
共 50 条
  • [21] Inhibition of c-Src reduces IL-6 expression in vivo and in vitro
    Peruzzi, B.
    Cappariello, A.
    Rucci, N.
    De Benedetti, F.
    Teti, A.
    BONE, 2009, 44 (02) : S249 - S249
  • [22] Higher sensitivity of IL-6 deficient mice to chemical oxidative hepatotoxicity and in vivo protection by an IL-6 receptor IL-6 chimera
    Katz, A
    Chebath, J
    Friedman, J
    Revel, M
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 329 - 329
  • [23] Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis
    Levy, Y
    Labaume, S
    Colombel, M
    Brouet, JC
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (01): : 167 - 172
  • [24] Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production
    Uchiyama, Yasushi
    Yoshida, Hiroto
    Koike, Nobuo
    Hayakawa, Naohiko
    Sugita, Atsuko
    Nishimura, Takashi
    Mihara, Masahiko
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (11) : 1595 - 1601
  • [25] Dose-dependent induction of IL-6 by plant-derived proteases in vitro
    Rose, B
    Herder, C
    Löffler, H
    Meierhoff, G
    Schloot, NC
    Walz, M
    Martin, S
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 143 (01): : 85 - 92
  • [26] IL-6 is necessary for the induction of hepcidin by inflammation
    Rivera, S
    Gabayan, V
    Ganz, T
    FASEB JOURNAL, 2004, 18 (04): : A152 - A152
  • [27] Induction of interleukins IL-6 and IL-8 by siRNA
    Pauls, E.
    Senserrich, J.
    Bofill, M.
    Clotet, B.
    Este, J. A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 147 (01): : 189 - 196
  • [28] Pyrano-isochromanones as IL-6 Inhibitors: Synthesis, in Vitro and in Vivo Antiarthritic Activity
    Jain, Shreyans K.
    Singh, Surjeet
    Khajuria, Anamika
    Guru, Santosh K.
    Joshi, Prashant
    Meena, Samdarshi
    Nadkarni, Janhavi R.
    Singh, Amarinder
    Bharate, Sonali S.
    Bhushan, Shashi
    Bharate, Sandip B.
    Vishwakarma, Ram A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (16) : 7085 - 7097
  • [29] β-adrenergic regulation of IL-6 release from adipose tissue:: In vivo and in vitro studies
    Mohamed-Ali, V
    Flower, L
    Sethi, J
    Hotamisligil, G
    Gray, R
    Humphries, SE
    York, DA
    Pinkney, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12): : 5864 - 5869
  • [30] In vitro and in vivo evaluations of IL-6 cytokine subfamily antagonists for the treatment of inflammatory arthritis
    Jazayeri, Jalal
    Raye, Warren
    Carroll, Graeme J.
    INFLAMMATION RESEARCH, 2005, 54 : S152 - S153